Nedsat leverfunktion: sikkerhed og effekt af Kaletra er ikke fastsat hos patienter med alvorlig grundlæggende leversygdom.
Hepatic impairment: the safety and efficacy of Kaletra has not been established in patients with significant underlying liver disorders.